NOF achieved higher revenue and profit in the first half of fiscal 2026 and raised its full-year earnings forecast. Strong shipments of cosmetics-related products in the Functional Chemicals segment contributed to the results.
NOF's consolidated results for the first half of fiscal 2026 showed increases in both revenue and profit, driven by higher shipments of cosmetics-related products in the Functional Chemicals segment and progress on construction projects in the Explosives segment. Overall, the company reported higher revenue and profit, with the difference between selling prices and costs providing a positive contribution during the period.
In the Functional Chemicals segment, strong shipments of cosmetics-related products were the main factor behind the increase in profit, while changes in variable costs, including inventory effects, also had an impact. The Pharmaceutical, Medical and Health Care segment reported lower revenue and profit, affected by the timing of shipments related to DDS. The Explosives segment secured higher revenue and profit as equipment installation progressed ahead of schedule.
The full-year earnings forecast was revised upward to revenue of ¥321.5 billion, operating profit of ¥50.5 billion, ordinary profit of ¥51.8 billion and net profit of ¥41.0 billion. EPS is expected to be ¥183. The interim and year-end dividends are expected to be raised to ¥37 each, or ¥74 for the full year. ROE was also revised upward to 13.8%.
NOF said it would continue investing in research and development and returning profits to shareholders, and would advance the development of new technologies in areas including life and healthcare in line with NOF VISION 2030. The company is strengthening its long-term growth strategy while improving its financial metrics.